Bank of America’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.5M | Buy |
66,338
+20,375
| +44% | +$3.93M | ﹤0.01% | 2784 |
|
|
2025
Q4 | $8.7M | Buy |
45,963
+3,519
| +8% | +$651K | ﹤0.01% | 2960 |
|
|
2025
Q3 | $7.03M | Sell |
42,444
-10,022
| -19% | -$1.63M | ﹤0.01% | 3668 |
|
|
2025
Q2 | $8.04M | Buy |
52,466
+7,898
| +18% | +$1.18M | ﹤0.01% | 3421 |
|
|
2025
Q1 | $7.01M | Sell |
44,568
-41,940
| -48% | -$6.81M | ﹤0.01% | 3477 |
|
|
2024
Q4 | $13.6M | Buy |
86,508
+40,052
| +86% | +$6.74M | ﹤0.01% | 2638 |
|
|
2024
Q3 | $8.24M | Sell |
46,456
-3,223
| -6% | -$572K | ﹤0.01% | 3253 |
|
|
2024
Q2 | $8.37M | Sell |
49,679
-609
| -1% | -$99.6K | ﹤0.01% | 3119 |
|
|
2024
Q1 | $8.36M | Sell |
50,288
-59,873
| -54% | -$9.91M | ﹤0.01% | 3155 |
|
|
2023
Q4 | $18.2M | Buy |
110,161
+56,859
| +107% | +$8.75M | ﹤0.01% | 2249 |
|
|
2023
Q3 | $8.3M | Buy |
53,302
+5,260
| +11% | +$840K | ﹤0.01% | 2905 |
|
|
2023
Q2 | $7.5M | Buy |
48,042
+2,615
| +6% | +$418K | ﹤0.01% | 2997 |
|
|
2023
Q1 | $7.36M | Buy |
45,427
+6,202
| +16% | +$1M | ﹤0.01% | 3125 |
|
|
2022
Q4 | $6.27M | Buy |
39,225
+4,316
| +12% | +$684K | ﹤0.01% | 3177 |
|
|
2022
Q3 | $4.92M | Sell |
34,909
-31,388
| -47% | -$4.75M | ﹤0.01% | 3371 |
|
|
2022
Q2 | $9.66M | Buy |
66,297
+6,659
| +11% | +$992K | ﹤0.01% | 2736 |
|
|
2022
Q1 | $9.67M | Sell |
59,638
-60,982
| -51% | -$9.88M | ﹤0.01% | 2896 |
|
|
2021
Q4 | $22.8M | Buy |
120,620
+88,226
| +272% | +$17M | ﹤0.01% | 2094 |
|
|
2021
Q3 | $6.55M | Buy |
32,394
+583
| +2% | +$122K | ﹤0.01% | 3296 |
|
|
2021
Q2 | $6.42M | Sell |
31,811
-1,596
| -5% | -$297K | ﹤0.01% | 3294 |
|
|
2021
Q1 | $5.86M | Buy |
33,407
+1,752
| +6% | +$317K | ﹤0.01% | 3252 |
|
|
2020
Q4 | $5.37M | Buy |
31,655
+779
| +3% | +$128K | ﹤0.01% | 3067 |
|
|
2020
Q3 | $5M | Sell |
30,876
-4,074
| -12% | -$663K | ﹤0.01% | 2914 |
|
|
2020
Q2 | $5.7M | Sell |
34,950
-30,054
| -46% | -$4.57M | ﹤0.01% | 2723 |
|
|
2020
Q1 | $8.32M | Buy |
65,004
+32,957
| +103% | +$4.44M | ﹤0.01% | 2215 |
|
|
2019
Q4 | $4.47M | Sell |
32,047
-2,456
| -7% | -$323K | ﹤0.01% | 3349 |
|
|
2019
Q3 | $4.07M | Sell |
34,503
-3,096
| -8% | -$385K | ﹤0.01% | 3397 |
|
|
2019
Q2 | $4.85M | Buy |
37,599
+8,049
| +27% | +$992K | ﹤0.01% | 3269 |
|
|
2019
Q1 | $3.8M | Buy |
29,550
+10,631
| +56% | +$1.34M | ﹤0.01% | 3426 |
|
|
2018
Q4 | $2.1M | Buy |
18,919
+5,678
| +43% | +$686K | ﹤0.01% | 3807 |
|
|
2018
Q3 | $1.8M | Sell |
13,241
-3,022
| -19% | -$393K | ﹤0.01% | 4060 |
|
|
2018
Q2 | $1.95M | Sell |
16,263
-1,490
| -8% | -$176K | ﹤0.01% | 3994 |
|
|
2018
Q1 | $2.14M | Sell |
17,753
-3,223
| -15% | -$404K | ﹤0.01% | 3830 |
|
|
2017
Q4 | $2.61M | Buy |
20,976
+4,152
| +25% | +$530K | ﹤0.01% | 3722 |
|
|
2017
Q3 | $2.26M | Buy |
16,824
+765
| +5% | +$99.6K | ﹤0.01% | 3883 |
|
|
2017
Q2 | $2.02M | Buy |
16,059
+1,485
| +10% | +$179K | ﹤0.01% | 3875 |
|
|
2017
Q1 | $1.74M | Sell |
14,574
-13,848
| -49% | -$1.62M | ﹤0.01% | 3995 |
|
|
2016
Q4 | $3.06M | Buy |
28,422
+22,524
| +382% | +$2.45M | ﹤0.01% | 3398 |
|
|
2016
Q3 | $680K | Sell |
5,898
-1,492
| -20% | -$170K | ﹤0.01% | 4418 |
|
|
2016
Q2 | $756K | Sell |
7,390
-3,037
| -29% | -$324K | ﹤0.01% | 4377 |
|
|
2016
Q1 | $1.08M | Sell |
10,427
-2,146
| -17% | -$224K | ﹤0.01% | 4055 |
|
|
2015
Q4 | $1.6M | Buy |
12,573
+1,171
| +10% | +$143K | ﹤0.01% | 3999 |
|
|
2015
Q3 | $1.3M | Sell |
11,402
-7,685
| -40% | -$1.02M | ﹤0.01% | 4132 |
|
|
2015
Q2 | $2.57M | Sell |
19,087
-10,008
| -34% | -$1.33M | ﹤0.01% | 3216 |
|
|
2015
Q1 | $3.77M | Buy |
29,095
+15,561
| +115% | +$1.96M | ﹤0.01% | 2709 |
|
|
2014
Q4 | $1.56M | Sell |
13,534
-2,804
| -17% | -$316K | ﹤0.01% | 3623 |
|
|
2014
Q3 | $1.73M | Buy |
16,338
+1,719
| +12% | +$174K | ﹤0.01% | 3517 |
|
|
2014
Q2 | $1.39M | Buy |
14,619
+4,994
| +52% | +$448K | ﹤0.01% | 3703 |
|
|
2014
Q1 | $875K | Sell |
9,625
-693
| -7% | -$67.4K | ﹤0.01% | 4038 |
|
|
2013
Q4 | $914K | Sell |
10,318
-4,794
| -32% | -$401K | ﹤0.01% | 4151 |
|
|
2013
Q3 | $1.25M | Buy |
15,112
+6,813
| +82% | +$535K | ﹤0.01% | 3724 |
|
|
2013
Q2 | $568K | Buy |
+8,299
| New | +$577K | ﹤0.01% | 4625 |
|
Other funds holding BBH
MIM
CCA
BFG
PPWM
Bank of America's BBH Position: Q1 2026 in Review
Bank of America increased its VanEck Biotech ETF (BBH) stake by 44% in Q1 2026, buying an estimated $3.93M and bringing the position to 66,338 shares worth $12.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2784.
Bank of America first reported a position in BBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $22.8M in Q4 2021. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.
- Bank of America held 66,338 shares of VanEck Biotech ETF worth $12.5M as of Q1 2026.
- Bank of America bought 20,375 VanEck Biotech ETF shares in Q1 2026, an estimated $3.93M.
- VanEck Biotech ETF made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2784 holding.
- Bank of America first reported a position in VanEck Biotech ETF in Q2 2013 and has held it in 52 quarters since.
- Bank of America's VanEck Biotech ETF position peaked at $22.8M in Q4 2021.
- 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.